Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Renin

Renin o carries out the first, rate-determining step in the renin-angiotensin cascade, and angiotensinogen is its only known substrate. It has been reasoned that this specificity may provide an opportunity for therapeutic intervention with few undesirable side effects. [Pg.10]

Having designed a (3-strand peptidomimetic using 3,5,5-linked pyrrolin-4-one units, 7 Smith et al. at the University of Pennsylvania and Merck [Pg.10]

The activities of renin in plasma and serum are measured in the diagnosis of hypertension. The natural substrate for renin is angiotensin. Several synthetic peptides have been used in renin assays. Recently, Nakamura-lmajo et al. (1992) used N-(2-pyridyl)glycine (pg) as a fluorescent tag on a nonapeptide. [Pg.246]

The assay was conducted by adding 10 / L of serum or plasma to 100 tiL containing 500 fiM substrate in 100 mM Mops-NaOH (pH 7.0), 1 mM phenylmethylsulfonyl fluoride, and 3 mM o-phenanthroline. The reaction mixture was incubated at 37°C for an hour, and then 60 fih was directly injected into the column. [Pg.246]

The assay is suitable for assaying enzyme in serum and plasma, and also recombinant human prorenin expressed in Chinese hamster ovary cells. Prorenin was activated by trypsin digestion. [Pg.246]

3 Structure-Based Design From Renin to HIV-1 Protease [Pg.38]

The crystal structures of aspartic proteases helped elucidate the meehanism of action for this family of enzymes. For example, in the crystal structure of native endothiapepsin, a water [Pg.38]

The residue side chains occupy subsites on alternate sides of the backbone, designated according to the nomenclature introduced by Schechter and Berger (PI, PI. .., SI, SI ) [19]. These experimental observations guided the design of inhibitor structures tailored to mimic [Pg.39]

There is no generally accepted Renin Unit. Schales and Haynes (155) defined one rabbit unit of renin (R.U.) as the amount of renin (expressed as micrograms of nitrogen) that was required per kilogram of body weight to cause a ri.se in blood pressure of 30 mm. Hg when injected intravenously into a lult rabbits. For the assay, at least four unanestketizcd animals were used and the blood pressure was measured in the artery of the ear by a membrane manometer (56). The extracts were injected intravenously in the right ear, which had been previously denervated, to prevent any effect on the blood pressure from introduction of the needle. [Pg.516]

It is important to inject such amounts of renin as will cause a rise in blood pressure between 20 and 40 mm. Hg as the response in this range is approximately proportional to the amount of renin given. It can be seen from the dose-response curve by Pickering and Prinzmetal (134) that this linearity is not present in the range above 40 mm. [Pg.516]

With increasing purity of an extract the amount of nitrogen associated with one ]R.U. will decrease as less inert proteins are present the rabbit ear method offers there- [Pg.516]

Effect of Human Renin on Humans, Dogs, and Rabbits (157) [Pg.517]

Effect on Mg. N/unit Units/kg. kidney Gram kidney for 1 unit [Pg.517]


ANPs play an important role in the maintenance of cardiovascular homeostasis by counterbalancing the renin—angiotensin (RAS) system. ANP, the main circulating form of the natriuretic peptides, effectively relaxes vascular smooth muscle, promotes the excretion of sodium and water, and in the CNS inhibits vasopressin release and antagonizes AT-II induced thirst. [Pg.528]

Kidney Function. Prostanoids influence a variety of kidney functions including renal blood flow, secretion of renin, glomerular filtration rate, and salt and water excretion. They do not have a critical role in modulating normal kidney function but play an important role when the kidney is under stress. Eor example, PGE2 and -I2 are renal vasodilators (70,71) and both are released as a result of various vasoconstrictor stimuli. They thus counterbalance the vasoconstrictor effects of the stimulus and prevent renal ischemia. The renal side effects of NSAIDS are primarily observed when normal kidney function is compromised. [Pg.155]

Patients having high plasma renin activity (PRA) (>8 ng/(mLh)) respond best to an ACE inhibitor or a -adrenoceptor blocker those having low PRA (<1 ng/(mLh)) usually elderly and black, respond best to a calcium channel blocker or a diuretic (184). -Adrenoceptor blockers should not be used in patients who have diabetes, asthma, bradycardia, or peripheral vascular diseases. The thiazide-type diuretics (qv) should be used with caution in patients having diabetes. Likewise, -adrenoceptor blockers should not be combined with verapamil or diltiazem because these dmgs slow the atrioventricular nodal conduction in the heart. Calcium channel blockers are preferred in patients having coronary insufficiency diseases because of the cardioprotective effects of these dmgs. [Pg.132]

In animal models, renin inhibitors after iv adrninistration have been shown to be equally efficacious as compared to ACE inhibitors in lowering blood pressure, and to have similar effects on the cardiovascular and renal parameters. Some of the renin inhibitors tested are enalkiren (A-64662), CGP 38 560A, CP 71362, KRI-1230, U-71039, ES6864, and PD-134672. The stmctures of enalkiren and the formula for PD-134672 are shown in Figure 4. [Pg.140]

Glonidine. Clonidine decreases blood pressure, heart rate, cardiac output, stroke volume, and total peripheral resistance. It activates central a2 adrenoceptors ia the brainstem vasomotor center and produces a prolonged hypotensive response. Clonidine, most efficaciously used concomitantly with a diuretic in long-term treatment, decreases renin and aldosterone secretion. [Pg.143]

Piaacidil has a short half-life and most human studies were carried out ia slow-release formulatioas. The reductioa ia blood pressure produced by piaacidil is accompanied by tachycardia and fluid retention. Plasma catecholamines and renin activity are iacreased. Other side effects are headache, di22iaess, and asthenia. [Pg.143]

In addition to being involved in the formation of urine, the kidney acts as an endocrine organ secreting renin, erythropoietin, prostaglandins (qv), and kinins it is also capable of synthesizing substances such as la,25-dihydroxycholecalciferol [32222-06-3] One of the principal functions of the... [Pg.202]

In normal human subjects, ANP infusion for one hour causes increased absolute and fractional sodium excretion, urine flow, GFR, and water clearance (53—55). As shown in many in vitro and in vivo animal studies, ANP achieves this by direct effect on the sodium reabsorption in the inner medullary collecting duct, ie, by reducing vasopressin-dependent free-water and sodium reabsorption leading to diuresis and by indirect effect through increased hemodynamic force upon the kidney. ANP inhibits the release of renin and aldosterone resulting in the decreased plasma renin activity and aldosterone concentration (56,57). [Pg.208]

In an attempt to conserve sodium, the kidney secretes renin increased plasma renin activity increases the release of aldosterone, which regulates the absorption of potassium and leads to kafluresis and hypokalemia. Hypokalemia is responsible in part for decreased glucose intolerance (82). Hyponatremia, postural hypotension, and pre-renal azotemia are considered of tittle consequence. Hypemricemia and hypercalcemia are not unusual, but are not considered harmful. However, hypokalemia, progressive decreased glucose tolerance, and increased semm cholesterol [57-88-5] levels are considered... [Pg.211]

Mammals, fungi, and higher plants produce a family of proteolytic enzymes known as aspartic proteases. These enzymes are active at acidic (or sometimes neutral) pH, and each possesses two aspartic acid residues at the active site. Aspartic proteases carry out a variety of functions (Table 16.3), including digestion pepsin and ehymosin), lysosomal protein degradation eathepsin D and E), and regulation of blood pressure renin is an aspartic protease involved in the production of an otensin, a hormone that stimulates smooth muscle contraction and reduces excretion of salts and fluid). The aspartic proteases display a variety of substrate specificities, but normally they are most active in the cleavage of peptide bonds between two hydrophobic amino acid residues. The preferred substrates of pepsin, for example, contain aromatic residues on both sides of the peptide bond to be cleaved. [Pg.519]

Renin Kidney Conversion of angiotensinogen to angiotensin I regulation of blood pressure... [Pg.520]

In some patients with hypertension and in all patients with cardiac failure, the renin-angiotensin system is activated to an undesired degree, burdening the heart. The consequences of diminished ANG II generation by ACE inhibitors are multiple. In patients with hypertension, blood pressure is reduced as a result... [Pg.9]

Blood Pressure Control Renin-Angiotensin-Aldosteron System... [Pg.11]

Bader M, Paul M, Fernandesz-Alfonso M et al (1994) Molecular biology and biochemistry of the renin-angiotensin system, Chap. 11. In Swales ID (ed) Textbook of hypertension. Blackwell Scientific Publications, Oxford, London, Edinburgh, pp 214-232... [Pg.11]

Bader M, Peters J, Baltatu O et al (2001)Tissue renin-angiotensin systems new insights from experimental animal models in hypertension research. J Mol Med 79 76-102... [Pg.11]

Renin-Angiotensin-Aldosterone System ACE Inhibitors Nuclear Factor-icB... [Pg.89]

By themselves, potassium-sparing agents are relatively weak antihypertensives. In general, there are four ways to reduce the activity of the RAS. The first way is the use of p-blockers to reduce renin release from the juxtaglomerular (JG). The second way, the direct inhibition of the activity of renin, although being actively investigated has not been successful in the clinical arena thus far. The third way is to inhibit the activity of the... [Pg.141]


See other pages where Renin is mentioned: [Pg.560]    [Pg.848]    [Pg.169]    [Pg.170]    [Pg.527]    [Pg.253]    [Pg.132]    [Pg.132]    [Pg.139]    [Pg.139]    [Pg.139]    [Pg.140]    [Pg.140]    [Pg.141]    [Pg.143]    [Pg.207]    [Pg.212]    [Pg.213]    [Pg.213]    [Pg.302]    [Pg.520]    [Pg.7]    [Pg.7]    [Pg.685]    [Pg.711]    [Pg.9]    [Pg.40]    [Pg.47]    [Pg.52]    [Pg.89]    [Pg.89]    [Pg.90]    [Pg.140]    [Pg.140]   
See also in sourсe #XX -- [ Pg.280 , Pg.340 ]

See also in sourсe #XX -- [ Pg.451 , Pg.452 ]

See also in sourсe #XX -- [ Pg.134 , Pg.333 ]

See also in sourсe #XX -- [ Pg.109 , Pg.123 ]

See also in sourсe #XX -- [ Pg.143 ]

See also in sourсe #XX -- [ Pg.13 , Pg.20 , Pg.82 , Pg.257 ]

See also in sourсe #XX -- [ Pg.184 ]

See also in sourсe #XX -- [ Pg.19 ]

See also in sourсe #XX -- [ Pg.136 ]

See also in sourсe #XX -- [ Pg.16 , Pg.18 ]

See also in sourсe #XX -- [ Pg.204 ]

See also in sourсe #XX -- [ Pg.124 , Pg.158 ]

See also in sourсe #XX -- [ Pg.330 , Pg.331 , Pg.427 ]

See also in sourсe #XX -- [ Pg.137 , Pg.138 , Pg.138 ]

See also in sourсe #XX -- [ Pg.130 ]

See also in sourсe #XX -- [ Pg.241 , Pg.250 , Pg.251 , Pg.252 , Pg.316 ]

See also in sourсe #XX -- [ Pg.109 , Pg.123 ]

See also in sourсe #XX -- [ Pg.311 , Pg.371 , Pg.372 ]

See also in sourсe #XX -- [ Pg.621 , Pg.1261 ]

See also in sourсe #XX -- [ Pg.235 ]

See also in sourсe #XX -- [ Pg.274 ]

See also in sourсe #XX -- [ Pg.29 ]

See also in sourсe #XX -- [ Pg.16 ]

See also in sourсe #XX -- [ Pg.76 ]

See also in sourсe #XX -- [ Pg.70 , Pg.71 , Pg.72 , Pg.73 , Pg.74 , Pg.75 , Pg.183 , Pg.185 , Pg.191 , Pg.262 ]

See also in sourсe #XX -- [ Pg.89 ]

See also in sourсe #XX -- [ Pg.56 ]

See also in sourсe #XX -- [ Pg.169 , Pg.175 , Pg.221 ]

See also in sourсe #XX -- [ Pg.368 , Pg.369 ]

See also in sourсe #XX -- [ Pg.697 , Pg.698 ]

See also in sourсe #XX -- [ Pg.519 ]

See also in sourсe #XX -- [ Pg.246 ]

See also in sourсe #XX -- [ Pg.3 ]

See also in sourсe #XX -- [ Pg.543 ]

See also in sourсe #XX -- [ Pg.467 ]

See also in sourсe #XX -- [ Pg.706 , Pg.708 , Pg.712 ]

See also in sourсe #XX -- [ Pg.621 ]

See also in sourсe #XX -- [ Pg.143 ]

See also in sourсe #XX -- [ Pg.109 , Pg.123 ]

See also in sourсe #XX -- [ Pg.1683 , Pg.2015 , Pg.2020 , Pg.2020 ]

See also in sourсe #XX -- [ Pg.203 ]

See also in sourсe #XX -- [ Pg.292 ]

See also in sourсe #XX -- [ Pg.37 , Pg.41 , Pg.43 , Pg.46 , Pg.50 , Pg.51 ]

See also in sourсe #XX -- [ Pg.753 ]

See also in sourсe #XX -- [ Pg.763 ]

See also in sourсe #XX -- [ Pg.419 , Pg.420 ]

See also in sourсe #XX -- [ Pg.125 ]

See also in sourсe #XX -- [ Pg.19 ]

See also in sourсe #XX -- [ Pg.621 ]

See also in sourсe #XX -- [ Pg.621 ]

See also in sourсe #XX -- [ Pg.454 ]

See also in sourсe #XX -- [ Pg.235 ]

See also in sourсe #XX -- [ Pg.672 ]

See also in sourсe #XX -- [ Pg.144 , Pg.148 ]

See also in sourсe #XX -- [ Pg.201 ]

See also in sourсe #XX -- [ Pg.189 ]

See also in sourсe #XX -- [ Pg.47 ]

See also in sourсe #XX -- [ Pg.10 ]

See also in sourсe #XX -- [ Pg.181 , Pg.182 ]

See also in sourсe #XX -- [ Pg.215 , Pg.227 ]

See also in sourсe #XX -- [ Pg.295 ]

See also in sourсe #XX -- [ Pg.94 ]

See also in sourсe #XX -- [ Pg.469 ]

See also in sourсe #XX -- [ Pg.256 , Pg.557 ]

See also in sourсe #XX -- [ Pg.216 ]

See also in sourсe #XX -- [ Pg.22 ]

See also in sourсe #XX -- [ Pg.555 ]

See also in sourсe #XX -- [ Pg.14 ]

See also in sourсe #XX -- [ Pg.105 , Pg.106 ]

See also in sourсe #XX -- [ Pg.145 , Pg.146 , Pg.147 , Pg.148 , Pg.149 , Pg.150 , Pg.154 ]

See also in sourсe #XX -- [ Pg.355 ]

See also in sourсe #XX -- [ Pg.124 , Pg.125 , Pg.126 , Pg.127 , Pg.128 , Pg.129 , Pg.130 , Pg.131 , Pg.132 , Pg.133 , Pg.134 ]

See also in sourсe #XX -- [ Pg.64 , Pg.195 ]

See also in sourсe #XX -- [ Pg.514 , Pg.516 , Pg.517 , Pg.518 , Pg.519 , Pg.520 , Pg.521 , Pg.522 , Pg.523 , Pg.539 , Pg.540 , Pg.541 , Pg.546 , Pg.547 , Pg.548 , Pg.549 ]




SEARCH



Active site renin

Affecting the Renin-Angiotensin System

Amino acid sequences, renin

Amino acid sequences, renin inhibitors

Angiotensin/renin modulators

Antihypertensive actions Renin-angiotensin system

Antihypertensive drugs Renin-Angiotensin-Aldosterone system

Antihypertensives renin inhibitors

Antihypertensives renin-angiotensin system agents

Big-renin

Cardiac Renin

Cardiovascular disease renin-angiotensin system

Comparative modelling renin

Cyclosporine renin-angiotensin system

Direct renin inhibitors

Enzyme specificity renin

Enzymes renin

Heart failure renin-angiotensin-aldosterone system

Hypertensin renin

Hypertension renin-angiotensin pathway

Hypertension renin-angiotensin-aldosterone system

Hypertension renin-dependent

Inhibitors, renin

Inhibitors, renin-angiotensin

Juxtaglomerular Renin

Kidney Renin-angiotensin system

Kidney renin

Kidney, renin level

Ligand binding renin inhibitors

Low-renin

Non-renin-angiotensin system agents

Pepstatin renin inhibitor

Peptide Hormones of the Kidney (Renin-Angiotensin System)

Peptidic renin inhibitors

Plasma renin

Plasma renin activity

Plasma renin concentration

Plasma renin measurement

Prostacyclin renin secretion stimulated

Purification renin

Release of renin

Renal disease, treatment renin-angiotensin system

Renal function renin-angiotensin system

Renal vein renin test

Renin Crystal Structure

Renin affinity chromatography

Renin and

Renin and kidney cathepsins

Renin angiotensin produced

Renin animal specificity

Renin assay

Renin catalytic site binding

Renin enzyme action

Renin enzyme properties

Renin enzymic nature

Renin extraction

Renin hypertension

Renin inhibition

Renin inhibitor development

Renin inhibitor, hypertension treatment

Renin inhibitors angiotensin system

Renin inhibitors applications

Renin inhibitors design/discovery

Renin inhibitors molecular modeling

Renin inhibitors transition state analogs

Renin inhibitory activity

Renin inhibitory peptide

Renin measurement

Renin model

Renin modeling

Renin precursors

Renin preparation

Renin release

Renin release from macula densa

Renin release inhibition

Renin release regulation

Renin structure

Renin substrate

Renin tolerance

Renin transition state analogues

Renin, aldosterone synthesis

Renin, human

Renin-Angiotensin-Aldosterone

Renin-Angiotensin-Aldosterone Axis

Renin-Angiotensin-Aldosterone cascade

Renin-aldosterone axis

Renin-angiotensin

Renin-angiotensin family

Renin-angiotensin pathway

Renin-angiotensin system

Renin-angiotensin system agents

Renin-angiotensin system effects

Renin-angiotensin system enzyme inhibitors

Renin-angiotensin system local

Renin-angiotensin system long-term

Renin-angiotensin system prostaglandins

Renin-angiotensin system, renal physiology

Renin-angiotensin-aldosterone mechanism

Renin-angiotensin-aldosterone mechanism fluid volume

Renin-angiotensin-aldosterone pathway

Renin-angiotensin-aldosterone syste

Renin-angiotensin-aldosterone system

Renin-angiotensin-aldosterone system RAAS)

Renin-angiotensin-aldosterone system blood pressure regulation

Renin-angiotensin-aldosterone system diuretics

Renin-angiotensin-aldosterone system inhibitors

Renin-angiotensin-aldosterone system vasodilators

Renin-angiotensin—aldosteron system

Renin-angiotensin—aldosteron system RAAS)

Renin-binding protein

Renin-hypertensin-hypertensinase

Renin-protein complex

Renin—angiotensin syste

Serum renin substrate

Sodium renin-angiotensin system

Submaxillary gland, renin

Summary Comparison of HIV-1 Protease versus Renin Structure-Based Design

The Renin-Angiotensin System

© 2024 chempedia.info